Medidata Partners with Canary Advisors to Amplify Patient-Centric Approach to Clinical Trial Technologies

May 25, 2023 — Medidata, a Dassault Systèmes company, is expanding its Patient Insights Program through a partnership with Canary Advisors, a consulting firm dedicated to patient-focused drug and device development.

Medidata’s Patient Insights Program infuses a patient-centric approach into the design and development of clinical trial protocols and technologies. Through this program, Medidata develops innovative workshops to guide the creation of patient-facing solutions to improve clinical trial experiences, expedite clinical trial delivery timelines, and bring therapies to market faster.

“As Medidata continues to reinforce its commitment to prioritizing the participant point of view, our partnership with Canary Advisors adds depth and breadth to our patient insights work,” said Anthony Costello, CEO of Medidata Patient Cloud. “The growth of our patient-centricity by design services has earned customer engagements in eConsent, patient registries, and decentralized clinical trials. Patient insights are deeply rooted in our culture and the way we do business.”

The Canary Advisors partnership will bolster Medidata offerings in patient-centric clinical studies and empathetic technology design. With the partnership’s expanded focus on decentralized trials, Medidata can accelerate the adoption of key insights, operationalize knowledge faster, and provide additional perspectives on best practices that enhance the patient experience. 

Contact: 

Tom Paolella
Senior Director, Corporate Communications & Affairs
+1-848-203-7596
thomas.paolella@3ds.com

Paul Oestreicher
External Communications Director
+1-917-522-4692
paul.oestreicher@3ds.com